发明名称 |
New 3-(2-(((1-(2-cyclohexylethyl)-5-(2,5-dimethoxy-4-methylphenyl)-1H-1,2,4-triazol-3-yl)amino)carbonyl)-6-methoxy-4,5-1H-indol-1-yl)propionic acid and its salts, useful in the treatment of e.g. schizophrenia, diabetes and obesity |
摘要 |
3-(2-(((1-(2-Cyclohexylethyl)-5-(2,5-dimethoxy-4-methylphenyl)-1H-1,2, 4-triazol-3-yl)amino)carbonyl)-6-methoxy-4,5-1H-indol-1-yl)propionic acid (I) and its solvates, hydrates, polymorphs or salts are new. Independent claims are included for included for the following: (1) salts of (I) obtained with ethanolamine (a), diethanolamine (b), diethylamine (c) or adamantanamine (d); (2) preparation of (I) by hydrolyzing a compound of formula (II); and if desired further converting into its solvates, hydrates, polymorphs and salts; and (3) use of (I) in the preparation of a medicament.
|
申请公布号 |
FR2815963(A1) |
申请公布日期 |
2002.05.03 |
申请号 |
FR20000013728 |
申请日期 |
2000.10.26 |
申请人 |
SANOFI-SYNTHELABO |
发明人 |
BIGNON ERIC;FREHEL DANIEL |
分类号 |
A61P3/00;C07D403/12;(IPC1-7):C07D403/12;A61K31/419 |
主分类号 |
A61P3/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|